Explore our materials

Filters

Results (3209)

Abstract

HIV

International Workshop on HIV Pediatrics 2021

The Baylor International Pediatric AIDS Initiative (BIPAI) Network’s progress towards the second and third UNAIDS 95-95-95 goals among CALHIV receiving care in pediatric HIV centers in six countries in sub-Saharan Africa.

Abstract

HIV

International Workshop on HIV Pediatrics 2021

Viral Load Coverage and Suppression Around COVID-19: Eswatini

Abstract

HIV

International Workshop on HIV Pediatrics 2021

Adherence to Antiretroviral Therapy among Children Living with HIV in North-Central Nigeria: a Qualitative Evaluation of Barriers and Facilitators among Caregivers

Abstract

HIV

International Workshop on HIV Pediatrics 2021

Adolescent and caregiver perspectives on an enhanced adherence counseling intervention for youth with suspected HIV treatment failure in Kenya

Abstract

HIV

International Workshop on HIV Pediatrics 2021

Challenges in the effective treatment of infant HIV undermine the potential impact of birth testing and neonatal ART: preliminary results from the LIFE trial in Mozambique and Tanzania

Abstract

HIV

International Workshop on HIV Pediatrics 2021

Successful Scale- Up of Optimal Antiretroviral Regimens and Improvement in Viral Suppression for Children and Adolescents Living with HIV Amidst COVID 19 Pandemic In Kenya

Abstract

HIV

International Workshop on HIV Pediatrics 2021

The road to success is paved with dolutegravir: Dolutegravir treatment success among in children and adolescents living with HIV (CALHIV) at the Baylor Tanzania Centres of Excellence.

Abstract

HIV

International Workshop on HIV Pediatrics 2021

HIV Drug Resistance Patterns Among Highly Treatment-Experienced Children, Adolescents and Young Adults in Sub-Saharan Africa

Abstract

HIV

International Workshop on HIV Pediatrics 2021

Early Trends in HIV Drug Resistance Mutations Among Pediatric and Young Adult (0-24 years) Clients in Sub-Saharan Africa

Abstract

HIV

International Workshop on HIV Pediatrics 2021

Mutations associated with ineffectiveness of HIV-1 protease inhibitors in children in Abidjan, Côte d'Ivoire

Abstract

HIV

International Workshop on HIV Pediatrics 2021

Neuropsychiatric manifestations and sleep disturbances in children and adolescents randomised to dolutegravir-based ART vs standard-of-care in the ODYSSEY trial

Abstract

HIV

International Workshop on HIV Pediatrics 2021

Explore our materials

Your Selection Clear All

Topic

Material Type

Event

The Baylor International Pediatric AIDS Initiative (BIPAI) Network’s progress towards the second and third UNAIDS 95-95-95 goals among CALHIV receiving care in pediatric HIV centers in six countries in sub-Saharan Africa.

Viral Load Coverage and Suppression Around COVID-19: Eswatini

Adherence to Antiretroviral Therapy among Children Living with HIV in North-Central Nigeria: a Qualitative Evaluation of Barriers and Facilitators among Caregivers

Adolescent and caregiver perspectives on an enhanced adherence counseling intervention for youth with suspected HIV treatment failure in Kenya

Challenges in the effective treatment of infant HIV undermine the potential impact of birth testing and neonatal ART: preliminary results from the LIFE trial in Mozambique and Tanzania

Successful Scale- Up of Optimal Antiretroviral Regimens and Improvement in Viral Suppression for Children and Adolescents Living with HIV Amidst COVID 19 Pandemic In Kenya

The road to success is paved with dolutegravir: Dolutegravir treatment success among in children and adolescents living with HIV (CALHIV) at the Baylor Tanzania Centres of Excellence.

HIV Drug Resistance Patterns Among Highly Treatment-Experienced Children, Adolescents and Young Adults in Sub-Saharan Africa

Early Trends in HIV Drug Resistance Mutations Among Pediatric and Young Adult (0-24 years) Clients in Sub-Saharan Africa

Mutations associated with ineffectiveness of HIV-1 protease inhibitors in children in Abidjan, Côte d'Ivoire

Neuropsychiatric manifestations and sleep disturbances in children and adolescents randomised to dolutegravir-based ART vs standard-of-care in the ODYSSEY trial

Effect of dolutegravir on folate and vitamin B12 status among HIV-infected children and adolescents in the ODYSSEY trial